Predictors in the outcome of125I brachytherapy as monotherapy for prostate cancer
Authors:
- Karel A HinnenKHKarel A Hinnen
- Marco van VulpenMVMarco van Vulpen
- 10 January 2011
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 11 (1) , 115-123
Abstract
A number of different prostate cancer treatment modalities exist. Nomograms are used to assist clinicians and patients in choosing the most appropriate treatment. However, the predicted outcome for (125)I brachytherapy is much worse than what would be expected considering the actual survival rates. This underestimation may result in suboptimal treatment decisions. Therefore, better predictors for outcome after (125)I brachytherapy are necessary. The following factors, which may either influence outcome or predict outcome after brachytherapy, are discussed: tumor characteristics and risk stratification, patient age at treatment, obesity, adjuvant androgen-deprivation therapy, prostate-specific antigen bounce, implantation technique and dosimetry. For the prediction of outcome after (125)I brachytherapy, as long as the quality of the implant is optimal, only high-risk prostate cancer was found to have a negative impact on outcome.Keywords
This publication has 76 references indexed in Scilit:
- Prostate Cancer Outcomes following Brachytherapy Are Superior to Those Predicted by the ProstogramInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Prostogram Predicted Brachytherapy Outcomes are Not Universally Accurate: An Analysis Based on the M. D. Anderson Cancer Center Experience With 125 Iodine BrachytherapyJournal of Urology, 2009
- Trends in Gleason Score: Concordance Between Biopsy and Prostatectomy over 15 YearsUrology, 2008
- A Contemporary Study Correlating Prostate Needle Biopsy and Radical Prostatectomy Gleason ScoreJournal of Urology, 2008
- Prostate Cancer and RaceCurrent Problems in Cancer, 2007
- Estimates of the cancer incidence and mortality in Europe in 2006Annals of Oncology, 2007
- Detection of clinical unilateral T3a prostate cancer – by digital rectal examination or transrectal ultrasonography?BJU International, 2006
- Staging Prostate Cancer with Dynamic Contrast-enhanced Endorectal MR Imaging prior to Radical Prostatectomy: Experienced versus Less Experienced ReadersRadiology, 2005
- Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1–T2 prostate cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancerThe Lancet Oncology, 2003